AU8112094A - Nedocromil sodium for the treatment of upper respiratory tract infections - Google Patents

Nedocromil sodium for the treatment of upper respiratory tract infections

Info

Publication number
AU8112094A
AU8112094A AU81120/94A AU8112094A AU8112094A AU 8112094 A AU8112094 A AU 8112094A AU 81120/94 A AU81120/94 A AU 81120/94A AU 8112094 A AU8112094 A AU 8112094A AU 8112094 A AU8112094 A AU 8112094A
Authority
AU
Australia
Prior art keywords
treatment
respiratory tract
upper respiratory
tract infections
nedocromil sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU81120/94A
Other languages
English (en)
Inventor
Alan Martin Edwards
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of AU8112094A publication Critical patent/AU8112094A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU81120/94A 1993-11-10 1994-11-08 Nedocromil sodium for the treatment of upper respiratory tract infections Abandoned AU8112094A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939323132A GB9323132D0 (en) 1993-11-10 1993-11-10 New pharmaceutical use
GB9323132 1993-11-10
PCT/GB1994/002454 WO1995013070A1 (fr) 1993-11-10 1994-11-08 Nedocromil-sodium destine au traitement des infections des voies respiratoires superieures

Publications (1)

Publication Number Publication Date
AU8112094A true AU8112094A (en) 1995-05-29

Family

ID=10744915

Family Applications (1)

Application Number Title Priority Date Filing Date
AU81120/94A Abandoned AU8112094A (en) 1993-11-10 1994-11-08 Nedocromil sodium for the treatment of upper respiratory tract infections

Country Status (5)

Country Link
AU (1) AU8112094A (fr)
GB (1) GB9323132D0 (fr)
IL (1) IL111538A0 (fr)
WO (1) WO1995013070A1 (fr)
ZA (1) ZA948741B (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA782473B (en) * 1977-05-04 1979-04-25 Fisons Ltd Benzo pyrano-quinolinones
GB8704773D0 (en) * 1987-02-28 1987-04-01 Fisons Plc Compounds
GB8712251D0 (en) * 1987-05-23 1987-07-01 Fisons Plc Formulation
GB8911259D0 (en) * 1989-05-17 1989-07-05 Fisons Plc Inhalation medicament

Also Published As

Publication number Publication date
GB9323132D0 (en) 1994-01-05
ZA948741B (en) 1995-05-04
WO1995013070A1 (fr) 1995-05-18
IL111538A0 (en) 1995-01-24

Similar Documents

Publication Publication Date Title
AU5016593A (en) Apparatus for the diagnosis of sleep apnea
AU7867994A (en) Hemofiltration of mediator-related diseases
AU4738496A (en) External fixator for distal radius fractures
AU5969490A (en) Steerable intramedullary fracture reduction device
AU7931194A (en) Apparatus for treatment of the oral cavity
AU4048295A (en) Peptide medicaments for the treatment of disease
AU2549797A (en) Xanthone analogs for the treatment of infectious diseases
GB9314598D0 (en) Medicament inhalers
AU8910891A (en) Treatment of lung diseases
AU1430492A (en) Pharmaceutical composition for the treatment of gastritis
AU9173191A (en) Medicaments for the treatment of papillomavirus diseases
AU2806692A (en) Medicament for the treatment of anxiety
AU5758594A (en) Treatment of viral infections
AU7310896A (en) Use of nitroflavonoids for the treatment of anxiety
AU1116895A (en) Use of theophylline for the manufacture of a medicament for the treatment of asthma
AU7503194A (en) Sodium cromoglycate for the treatment of upper respiratory tract infections
AU2748895A (en) Medical nebuliser
AU6927894A (en) 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions
GB2282126B (en) An aid for the transfer of patients
AU4476089A (en) Use of azepinone derivatives for the treatment of respiratory tract disorders
AU3574793A (en) Remedy for airway diseases
AU1630895A (en) Treatment of H. pylori infections
AU4081393A (en) Medicaments for the treatment of anxiety
AU6387994A (en) Device for medical treatment
AU3530395A (en) Treatment of viral infections